Xtandi

Xtandi Indications/Uses

enzalutamide

Manufacturer:

Astellas Pharma

Distributor:

DKSH
Full Prescribing Info
Indications/Uses
XTANDI is indicated for: The treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (CRPC) (see Pharmacology: Pharmacodynamics under Actions).
The treatment of adult men with metastatic CRPC who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see Pharmacology: Pharmacodynamics under Actions).
The treatment of adult men with metastatic CRPC whose disease has progressed on or after docetaxel therapy.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in